A long-term investigation of the anti-hepatocarcinogenic potential of an indigenous medicine comprised of Nigella sativa, Hemidesmus indicus and Smilax glabra
- PMID: 16684351
- PMCID: PMC1475831
- DOI: 10.1186/1477-3163-5-11
A long-term investigation of the anti-hepatocarcinogenic potential of an indigenous medicine comprised of Nigella sativa, Hemidesmus indicus and Smilax glabra
Abstract
Background: A decoction comprised of Nigella sativa seeds, Hemidesmus indicus root bark and Smilax glabra rhizome is being recommended for cancer patients by a family of traditional medical practitioners of Sri Lanka. Previous investigations have demonstrated that a short term (10 weeks) treatment with the decoction can significantly inhibit diethylnitrosamine (DEN) mediated expression of Glutathione S-transferase P form (GST-P) in rat liver. The objective of the present investigation was to determine whether long term (16 months) treatment with the decoction would be successful in inhibiting in rat livers, not only DEN- mediated expression of GST-P, but also the carcinogen mediated development of overt tumours (OT) or histopathological changes leading to tumour development (HT).
Methods: Thirty-six male Wistar rats were divided into 3 groups of 12 each. Groups 1 and 2 were injected intraperitoneally (i.p) with DEN (200 mg/kg) while group 3 was injected normal saline (NS). Twenty-four hours later, decoction (DC; 6 g/kg body weight/day) was orally administered to group 1 rats, while groups 2 and 3 (DEN-control and normal control) were given distilled water (DW). Treatment with DC or DW continued for 16 months. At the end of the 9th month and 16th months (study 1 and study 2 respectively), six rats from each group were sacrificed, and livers observed for OT or HT, both visually and by subjecting liver sections to staining with Haemotoxylin and Eosin (H & E), Sweet's Silver stain (for reticulin fibers), Periodic Acid Schiff (PAS) staining (for glycogen), and immunohistochemical staining (for GST-P).
Results: At the end of 9 months (study 1) a hepatocellular adenoma (HA) developed in one of the rats in the DEN + DW treated group (group 2). At the end of 16 months (study 2), livers of all rats of group 2 developed OT and HT. Large areas of GST-P positive foci were also observed. No OT, HT or GST-P positive foci were detected in any of the other groups.
Conclusion: Protection against DEN-mediated carcinogenic changes in rat liver can be achieved by long term treatment with the DC comprised of N. sativa seeds, S. glabra rhizome and H. indicus root bark.
Figures
Similar articles
-
Protection against diethylnitrosoamine-induced hepatocarcinogenesis by an indigenous medicine comprised of Nigella sativa, Hemidesmus indicus and Smilax glabra: a preliminary study.J Carcinog. 2003 Oct 18;2(1):6. doi: 10.1186/1477-3163-2-6. J Carcinog. 2003. PMID: 14613573 Free PMC article.
-
Modulation of apoptosis in human hepatocellular carcinoma (HepG2 cells) by a standardized herbal decoction of Nigella sativa seeds, Hemidesmus indicus roots and Smilax glabra rhizomes with anti- hepatocarcinogenic effects.BMC Complement Altern Med. 2012 Mar 29;12:25. doi: 10.1186/1472-6882-12-25. BMC Complement Altern Med. 2012. PMID: 22458551 Free PMC article.
-
Cytotoxic effects of a decoction of Nigella sativa, Hemidesmus indicus and Smilax glabra on human hepatoma HepG2 cells.Life Sci. 2005 Aug 5;77(12):1319-30. doi: 10.1016/j.lfs.2005.01.022. Life Sci. 2005. PMID: 15916774
-
Anti-Inflammatory Activity Is a Possible Mechanism by Which the Polyherbal Formulation Comprised of Nigella sativa (Seeds), Hemidesmus indicus (Root), and Smilax glabra (Rhizome) Mediates Its Antihepatocarcinogenic Effects.Evid Based Complement Alternat Med. 2012;2012:108626. doi: 10.1155/2012/108626. Epub 2012 Nov 13. Evid Based Complement Alternat Med. 2012. PMID: 23243426 Free PMC article.
-
A comparison of the cytotoxic potential of standardized aqueous and ethanolic extracts of a polyherbal mixture comprised of Nigella sativa (seeds), Hemidesmus indicus (roots) and Smilax glabra (rhizome).Pharmacognosy Res. 2010 Nov;2(6):335-42. doi: 10.4103/0974-8490.75451. Pharmacognosy Res. 2010. PMID: 21713135 Free PMC article.
Cited by
-
Preclinical Evaluation of Dimethyl Itaconate Against Hepatocellular Carcinoma via Activation of the e/iNOS-Mediated NF-κB-Dependent Apoptotic Pathway.Front Pharmacol. 2022 Jan 14;12:823285. doi: 10.3389/fphar.2021.823285. eCollection 2021. Front Pharmacol. 2022. PMID: 35095533 Free PMC article.
-
Medicinal plants commonly used against cancer in traditional medicine formulae in Sri Lanka.Saudi Pharm J. 2019 May;27(4):565-573. doi: 10.1016/j.jsps.2019.02.004. Epub 2019 Feb 7. Saudi Pharm J. 2019. PMID: 31061626 Free PMC article. Review.
-
Protective Effect of a Polyherbal Aqueous Extract Comprised of Nigella sativa (Seeds), Hemidesmus indicus (Roots), and Smilax glabra (Rhizome) on Bleomycin Induced Cytogenetic Damage in Human Lymphocytes.Biomed Res Int. 2017;2017:1856713. doi: 10.1155/2017/1856713. Epub 2017 May 25. Biomed Res Int. 2017. PMID: 28626752 Free PMC article.
-
The effects of Nigella sativa on thyroid function, serum Vascular Endothelial Growth Factor (VEGF) - 1, Nesfatin-1 and anthropometric features in patients with Hashimoto's thyroiditis: a randomized controlled trial.BMC Complement Altern Med. 2016 Nov 16;16(1):471. doi: 10.1186/s12906-016-1432-2. BMC Complement Altern Med. 2016. PMID: 27852303 Free PMC article. Clinical Trial.
-
Recent advances on the anti-cancer properties of Nigella sativa, a widely used food additive.J Ayurveda Integr Med. 2016 Jul-Sep;7(3):173-180. doi: 10.1016/j.jaim.2016.07.004. Epub 2016 Sep 17. J Ayurveda Integr Med. 2016. PMID: 27649635 Free PMC article. Review.
References
-
- Iddamaldeniya SS, Wickramasinghe N, Thabrew I, Ratnatunge N, Thammitiyagodage M. Protection against diethylnitrosamine induced hepatocarcinogenesis by an indigenous medicine comprised of Nigella sativa, Hemidesmus indicus, and Smilax glabra: A preliminary study. J Carcinogenesis. 2003;2:6–11. doi: 10.1186/1477-3163-2-6. - DOI - PMC - PubMed
-
- Sabourdy MA. Breeding and Care of laboratory animals. Vol. 1. WHO Health Laboratory Technology Unit, Geneva, Switzerland; 1988. pp. 18–19.
-
- Ito N, Tsuda H, Hasagawa R, Imaida K. Sequential observation of pathomorphologic alterations in preneoplastic lesions during the promoting stage of hepatocarcinogenesis and the development of short -term system for hepatopromoters and hepatocarcinogens. Toxicology and Pathology. 1982;10:37–49. - PubMed
-
- Higgins GM, Anderson RM. Experimental pathology of the liver: Restoration of the liver of the white rat following partial surgical removal. Archives of Pahtology. 1931;12:186–202.
-
- Alan S, Ian W. The haematoxylin and eosin. In: John DB, Alan S, editor. theory and practice of histological techniques. Whitehall Books Ltd, Welington, New Zealand; 1996. pp. 212–9.
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
